Kotecha, D., Flather, M. D., Atar, D., Collins, P., Pepper, J., Jenkins, E., . . . Study, o. b. o. t. A. R. M. i. C. A. D. (. (2019). B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease. BMC.
シカゴスタイル引用形Kotecha, Dipak, Marcus D. Flather, Dan Atar, Peter Collins, John Pepper, Elizabeth Jenkins, Christopher M. Reid, David Eccleston, , on behalf of the Alternative Risk Markers in Coronary Artery Disease (ARM-CAD) Study. B-type Natriuretic Peptide Trumps Other Prognostic Markers in Patients Assessed for Coronary Disease. BMC, 2019.
MLA引用形式Kotecha, Dipak, et al. B-type Natriuretic Peptide Trumps Other Prognostic Markers in Patients Assessed for Coronary Disease. BMC, 2019.
警告: この引用は必ずしも正確ではありません.